Regencell Corp (RGC): Narxning daromadga nisbati
Klassik nevrologiya sohasidagi texnologik gigantlar bilan raqobatlashish Regencell Bioscience (RGC) uchun jiddiy omon qolish xavflarini yuzaga keltiradi. Ushbu tarixiy P/S grafigi bozor kutuvlarining dinamikasini aks ettiradi, bunda darajasi joriy koeffitsientni ko'rsatadi. Aktiv autizmni Xitoy tabibligi usullari orqali davolashning tor yo'nalishiga tayanadi, bu esa G'arb investorlari orasida shubhalarni uyg'otadi va uning yuqori darajadagi spekulyativ instrument sifatidagi obro'sini shakllantiradi.
Regencell (RGC) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Regencell Bioscience|RGC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Regencell Corp|RGC - Kompaniya qarzlari|Sof aktivlarga qarzlar Regencell|RGC - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Regencell Bioscience|Oraliq qoplama koeffitsiyenti regencellbioscience.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
RGC - Sof foyda|Kutilayotgan sof foyda Regencell Bioscience|RGC - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Regencell Bioscience Ltd|RGC - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Regencell|RGC - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Regencell Bioscience|RGC - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi regencellbioscience.com|RGC - Joriy yilda foyda o'sishi|Keyingi yil uchun bitta aksiya uchun sof foyda o'sishi prognozi Regencell Bioscience
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:RGC, regencellbioscience.com
Daromadlari kengroq iqtisodiyotdan ko'ra innovatsion tibbiy sikllarga bog'liq bo'lgan Regencell Bioscience (RGC) uchun tushumlar asosiy baholash bazasi bo'lib xizmat qiladi. Bozor kapitalizatsiyasining savdo hajmi nisbati, kompaniyaning dinamik P/S ko'rsatkichi orqali aks etgan holda, investorlarga narxlardagi shovqinni filtrlash va biznesning adolatli qiymatini uning operatsion miqyosiga nisbatan aniqlash imkonini beradi, bunda past qiymatlar narxning tiklanish potentsialidan dalolat beradi.
Raqobatdosh kompaniyalar
Narxning daromadga nisbati BIIB (biogen.com)|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|Axsome - Narxning daromadga nisbati|ACAD: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati XENE (Xenon Corp)|VKTX: P/S multiplikatori|SUPN (supernus.com) - Narxning daromadga nisbati|CPRX (Catalyst Pharmaceuticals, Inc.) - P/S multiplikatori|Denali (DNLI) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Harmony Pharma (HRMY)|BHVN - Sotuvga nisbatan narx|Narxning daromadga nisbati Amylyx Pharmaceuticals AMLX|Narx/daromad koeffitsiyenti trevitherapeutics.com (TRVI)|Praxis Precision Medicines, Inc. - P/S multiplikatori|Anavex (AVXL) - Kapitalizatsiyaning daromadga nisbati|CBLL: P/S multiplikatori|PRTA - Narx/daromad koeffitsiyenti|ALEC (Alector Inc.) - P/S multiplikatori|Sotuvga nisbatan narx annexonbio.com ANNX|Narxning daromadga nisbati Omeros Corporation (OMER)|Neurogene Inc - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ACIU (AC Immune Corp)|VYGR - Kapitalizatsiyaning daromadga nisbati|Neumora Therapeutics - P/S multiplikatori|Sotuvga nisbatan narx scilexholding.com|Tevogen Bio (TVGN) - Narxning daromadga nisbati|Alpha Cognition Inc. - Bozor kapitallashuvining daromadga nisbati|CGTX (Cognition Therapeutics, Inc.) - P/S multiplikatori|IKT - Narx/daromad multiplikatori|P/S multiplikatori SAVA|Kapitalizatsiyaning daromadga nisbati assertiotx.com ASRT|Narxning daromadga nisbati Coya Therapeutics COYA|VTGN: Kapitalizatsiya va daromad nisbati|Ovid Rx - P/S multiplikatori|Sotuvga nisbatan narx Acumen Pharmaceuticals, Inc|CRVO (CervoMed Inc.) - Kapitalizatsiyaning daromadga nisbati|Alterity Therapeutics Limited (ATHE) - P/S multiplikatori|Narxning daromadga nisbati Clene Inc|PEPG: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|RLMD - Sotuvga nisbatan narx|Narxning daromadga nisbati Annovis Bio, Inc. ANVS|Bozor kapitallashuvining daromadga nisbati GRCE|Firefly Neuroscience - P/S multiplikatori|Sotuvga nisbatan narx Klotho Neurosciences Inc|NRSN: P/S multiplikatori|Narx/daromad multiplikatori Reviva Pharmaceuticals, Inc. RVPH|MTVA (MetaVia Inc.) - P/S multiplikatori|Sotuvga nisbatan narx neuraxis.com NRXS|Narxning daromadga nisbati Helius Medical (HSDT)|passagebio.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV - Kapitalizatsiyaning daromadga nisbati|Athira Pharma, Inc. - P/S multiplikatori|Sotuvga nisbatan narx addextherapeutics.com|alzamend.com (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Protagenic Therapeutics Inc.|Narxning daromadga nisbati KTTA|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent, Inc.)|ATXI (avenuetx.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCLI (BrainStorm Cell Therapeutics)|Cara Therapeutics Inc. - Narxning daromadga nisbati|Chromocell Therapeutics Corporation - P/S multiplikatori|Narx/daromad koeffitsiyenti Eliem Therapeutics ELYM|intracellulartherapies.com (ITCI) - Narxning daromadga nisbati|Sotuvga nisbatan narx longboardpharma.com (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGen Biotech Inc (NKGN) - Narx/daromad koeffitsiyenti|P/S multiplikatori NRBO|Kapitalizatsiyaning daromadga nisbati Sage Therapeutics Inc SAGE|P/S multiplikatori SNPX (Synaptogenix, Inc.)|Narx/daromad koeffitsiyenti trevena.com (TRVN)|Vigil Neuro - P/S multiplikatori|Sotuvga nisbatan narx anewmeds.com|Cerevel (CERE) - Narxning daromadga nisbati
